X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21435) 21435
Publication (2334) 2334
Book Review (242) 242
Book Chapter (132) 132
Conference Proceeding (75) 75
Book / eBook (51) 51
Dissertation (27) 27
Web Resource (9) 9
Magazine Article (5) 5
Reference (4) 4
Data Set (2) 2
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (17505) 17505
index medicus (12898) 12898
neuroprotective agents - pharmacology (12708) 12708
neurosciences (10100) 10100
rats (9538) 9538
male (8808) 8808
humans (7309) 7309
neuroprotective agents - therapeutic use (6410) 6410
neuroprotection (6158) 6158
mice (5118) 5118
oxidative stress (4893) 4893
brain (4478) 4478
neurons - drug effects (4436) 4436
rats, sprague-dawley (4366) 4366
disease models, animal (4348) 4348
apoptosis (3997) 3997
pharmacology & pharmacy (3852) 3852
neurons (3534) 3534
neurology (3466) 3466
female (3012) 3012
rats, wistar (2932) 2932
biochemistry & molecular biology (2921) 2921
apoptosis - drug effects (2811) 2811
cells, cultured (2747) 2747
neurons - metabolism (2733) 2733
analysis (2711) 2711
ischemia (2399) 2399
dose-response relationship, drug (2383) 2383
brain - drug effects (2325) 2325
alzheimers-disease (2297) 2297
oxidative stress - drug effects (2285) 2285
neuroprotective agents - administration & dosage (2263) 2263
stroke (2210) 2210
cell survival - drug effects (2118) 2118
clinical neurology (2023) 2023
cell biology (1935) 1935
brain - metabolism (1843) 1843
expression (1842) 1842
neurons - pathology (1802) 1802
alzheimer's disease (1765) 1765
inflammation (1748) 1748
mice, inbred c57bl (1739) 1739
hippocampus - drug effects (1674) 1674
activation (1641) 1641
rodents (1575) 1575
neuroprotective agents (1564) 1564
parkinson's disease (1552) 1552
in-vitro (1549) 1549
biomedicine (1547) 1547
antioxidants (1545) 1545
neurodegeneration (1537) 1537
neuroprotective agents - metabolism (1532) 1532
cell-death (1530) 1530
signal transduction - drug effects (1522) 1522
neurotoxicity (1500) 1500
time factors (1494) 1494
brain - pathology (1468) 1468
article (1453) 1453
glutamate (1445) 1445
parkinsons-disease (1433) 1433
cell death - drug effects (1378) 1378
brain ischemia - drug therapy (1307) 1307
rat (1271) 1271
hippocampus (1256) 1256
research (1253) 1253
reactive oxygen species - metabolism (1241) 1241
antioxidants - pharmacology (1240) 1240
injuries (1191) 1191
immunohistochemistry (1180) 1180
proteins (1180) 1180
neurodegenerative diseases (1129) 1129
cerebral-ischemia (1128) 1128
central-nervous-system (1126) 1126
cell death (1118) 1118
hippocampus - metabolism (1115) 1115
focal cerebral-ischemia (1106) 1106
in-vivo (1103) 1103
pc12 cells (1099) 1099
health aspects (1098) 1098
nervous system diseases (1077) 1077
neuroprotective agents - chemistry (1072) 1072
cells (1070) 1070
injury (1056) 1056
physiological aspects (1041) 1041
inhibition (1028) 1028
animals, newborn (995) 995
treatment outcome (992) 992
brain ischemia - pathology (991) 991
nervous system (983) 983
cerebral ischemia (955) 955
cell line, tumor (939) 939
mechanisms (932) 932
model (931) 931
rat-brain (923) 923
neurons - cytology (912) 912
endocrinology & metabolism (909) 909
mitochondria (905) 905
chemistry, medicinal (891) 891
brain ischemia - metabolism (884) 884
damage (883) 883
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21320) 21320
Japanese (162) 162
Chinese (69) 69
French (58) 58
Russian (55) 55
German (36) 36
Polish (22) 22
Hungarian (15) 15
Spanish (15) 15
Korean (12) 12
Portuguese (5) 5
Ukrainian (2) 2
Bulgarian (1) 1
Catalan (1) 1
Czech (1) 1
Danish (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Neuroscience, ISSN 1097-6256, 05/2009, Volume 12, Issue 5, pp. 627 - 636
The mechanisms underlying disease manifestations in neurodegeneration remain unclear, but their understanding is critical to devising effective therapies. We... 
NEURODEGENERATIVE DISEASE | UNFOLDED PROTEIN RESPONSE | MOTOR-NEURON DEGENERATION | WILD-TYPE SOD1 | ALS-LINKED SOD1 | MOUSE MODEL | AMYOTROPHIC-LATERAL-SCLEROSIS | ENDOPLASMIC-RETICULUM STRESS | MUTANT SUPEROXIDE-DISMUTASE | NEUROSCIENCES | TRANSGENIC MICE | Microglia - metabolism | Central Nervous System - metabolism | Amyotrophic Lateral Sclerosis - physiopathology | Ubiquitin - metabolism | Central Nervous System - pathology | Endoplasmic Reticulum - metabolism | Gliosis - physiopathology | Thiourea - pharmacology | Mice, Neurologic Mutants | Motor Neurons - classification | Motor Neurons - pathology | Ubiquitination | Neuroprotective Agents - pharmacology | Disease Models, Animal | Wallerian Degeneration - genetics | Biomarkers - metabolism | Genetic Predisposition to Disease - genetics | Gliosis - genetics | Endoplasmic Reticulum - genetics | Wallerian Degeneration - metabolism | Amyotrophic Lateral Sclerosis - genetics | Gliosis - metabolism | Wallerian Degeneration - physiopathology | Biomarkers - analysis | Oxidative Stress - genetics | Cinnamates - pharmacology | Disease Progression | Protein Folding | Motor Neurons - metabolism | Phenotype | Animals | Amyotrophic Lateral Sclerosis - metabolism | Mice | Central Nervous System - physiopathology | Thiourea - analogs & derivatives | Motor neurons | Physiological aspects | Amyotrophic lateral sclerosis | Nervous system | Degeneration | Research | Endoplasmic reticulum
Journal Article
Journal Article
Food and Chemical Toxicology, ISSN 0278-6915, 09/2015, Volume 83, pp. 111 - 124
The concept of using phytochemicals has ushered in a new revolution in pharmaceuticals. Naturally occurring polyphenols (like curcumin, morin, resveratrol,... 
Neurodegenerative disease | Curcumin | Inflammation | Diabetes | Antioxidant | Cancer | OXIDATIVE STRESS | WINGLESS SIGNALING PATHWAY | FOOD SCIENCE & TECHNOLOGY | DOWN-REGULATION | CELL-CYCLE ARREST | ENDOPLASMIC-RETICULUM STRESS | FORKHEAD TRANSCRIPTION FACTORS | ARJUNOLIC ACID | IN-VITRO | RETRACTED ARTICLE. SEE | TOXICOLOGY | NF-KAPPA-B | Neoplasms - metabolism | Neuroprotective Agents - therapeutic use | Arthritis - metabolism | Hypoglycemic Agents - metabolism | Antioxidants - metabolism | Cardiovascular Diseases - prevention & control | Humans | Neurodegenerative Diseases - prevention & control | Neoplasms - prevention & control | Curcumin - metabolism | Neuroprotective Agents - metabolism | Antineoplastic Agents, Phytogenic - metabolism | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Dietary Supplements - adverse effects | Neuroprotective Agents - adverse effects | Antineoplastic Agents, Phytogenic - therapeutic use | Arthritis - prevention & control | Antineoplastic Agents, Phytogenic - adverse effects | Diabetes Complications - prevention & control | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - metabolism | Curcumin - therapeutic use | Diabetes Complications - metabolism | Curcumin - adverse effects | Neurodegenerative Diseases - metabolism | Antioxidants - therapeutic use | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Antioxidants - adverse effects | Hypoglycemic Agents - adverse effects | Antioxidants | Polyphenols | Nervous system diseases | Arthritis | Resveratrol | Index Medicus
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 06/2015, Volume 133, Issue 5, pp. 700 - 707
Journal Article